Martin Gajdošík Selected Research

Insulin Resistance

1/2020	Metabolic effects of a prolonged, very-high-dose dietary fructose challenge in healthy subjects.
1/2019	Reduced hepatocellular lipid accumulation and energy metabolism in patients with long standing type 1 diabetes mellitus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Gajdošík Research Topics

Disease

3	Non-alcoholic Fatty Liver Disease 01/2020 - 07/2014
2	Insulin Resistance 01/2020 - 01/2019
1	Brain Concussion (Cerebral Concussion) 01/2023
1	Digestive System Diseases 01/2022
1	Bile Duct Diseases (Bile Duct Disease) 01/2022
1	Body Weight (Weight, Body) 01/2020
1	Hypoglycemia (Reactive Hypoglycemia) 01/2019
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2019
1	Overweight 01/2019
1	Metabolic Diseases (Metabolic Disease) 01/2019
1	Obesity 01/2019
1	Type 2 Diabetes Mellitus (MODY) 01/2019
1	Inflammation (Inflammations) 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Hemorrhage 08/2014

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 01/2020 - 08/2014
3	Adenosine Triphosphate (ATP)IBA 01/2019 - 07/2014
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2022
2	Liver GlycogenIBA 01/2020 - 01/2019
1	Protons (Proton)IBA 01/2023
1	Phosphatidylcholines (Phosphatidylcholine)IBA 01/2022
1	FructoseIBA 01/2020
1	Glucose (Dextrose)FDA LinkGeneric 01/2020
1	GlycogenIBA 01/2020
1	Insulin (Novolin)FDA Link 01/2020
1	Transaminases (Aminotransferases)IBA 01/2019
1	Antisense OligonucleotidesIBA 01/2019
1	Glucagon Receptors (Glucagon Receptor)IBA 01/2019
1	LDL CholesterolIBA 01/2019
1	Metformin (Glucophage)FDA LinkGeneric 01/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	Membrane LipidsIBA 10/2017

Therapy/Procedure

1	Subcutaneous Injections 01/2019
1	Therapeutics 01/2019